News for Cardiol Therapeutics Inc. (CRDL.TO)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

Cardiol Therapeutics (CRDL) has caught the attention of H.C. Wainwright, which has launched coverage on the company with a Buy recommendation and a price target

Cardiol Therapeutics (CRDL) held its Annual General Meeting where all management resolutions were approved. Dr. Timothy Garnett, former CMO of Eli Lilly

Cardiol Therapeutics (CRDL) schedules its virtual Annual General Meeting for May 28, 2025. Shareholders can participate in the AGM via a live audio webc

Cardiol Therapeutics (CRDL) has nominated Dr. Timothy Garnett, former Chief Medical Officer of Eli Lilly, to its Board of Directors. The nomination alig

\n Cardiol Therapeutics (CRDL) has commenced its pivotal Phase III MAVERIC trial with the enrollment of the first patient. The trial will assess the effica

**media[578200]**

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis

Cardiol Therapeutics' Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024

New York-based WW International, Inc. (WW) is up over 54 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Hele...

Cardiol Therapeutics announces public offering of shares

Shares of Cardiol Therapeutics Inc (CRDL) surged 8.74% in mid-day trading on Sep 9. The stock reached an intraday high of $2.00, before settling at $1.99, u

Maryland-based biotechnology company Gain Therapeutics, Inc. (GANX) is down over 27 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

CARDIOL THERAPEUTICS INC. CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS THREE MONTHS ENDED MARCH 31, 2024 ...

Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028.

In this piece, we will take a look at the 11 best small cap pharma stocks to invest in.

Gainers Near Intelligence, Inc. (NASDAQ: NIR) shares rose 34.1% to $0.2801 in pre-market trading after falling 42% on Wednesday. Near Intelligence recently named its General Counsel, Jay Angelo, to also serve as the company’s Chief Privacy Officer.

Gainers Bright Green Corp. (NASDAQ: BGXX) jumped 90.5% to close at $48.08 on Wednesday. Bright Green Corporation, went public on the NASDAQ Tuesday, becoming the first U.S. plant-touching company to list on a major U.S. stock exchange.